References
- Sherief LM, Elsafy UR, Abdelkhalek ER, et al. Hodgkin lymphoma in childhood: clinicopathological features and therapy outcome at 2 centers from a developing country. Medicine. 2015;94(15):e670.
- Radhakrishnan V, Kapoor G, Arora B, et al. Management of Hodgkins Lymphoma: ICMR Consensus Document. Indian J Pediatr. 2017;84(5):371–381.
- Kelly KM. Hodgkin lymphoma in children and adolescents: improving the therapeutic index. Blood. 2015;126(22):2452–2458.
- Molyneux E, Scanlan T, Chagaluka G, et al. Haematological cancers in African children: progress and challenges. Br J Haematol. 2017;177(6):971–978.
- White Y, Castle VP, Haig A. Pediatric oncology in developing countries: challenges and solutions. J Pediatr. 2013;162(6):1090–1091.
- Ganesan P, Kumar L, Raina V, et al. Hodgkin’s lymphoma-long-term outcome: an experience from a tertiary care cancer center in North India. Ann Hematol. 2011;90(10):1153–1160.
- Faizan M, Taj MM, Anwar S, et al. Comparison of presentation and outcome in 100 pediatric hodgkin lymphoma patients treated at children hospital, Lahore, Pakistan and Royal Marsden Hospital, UK. J Coll Physicians Surg Pak. 2016;26(11):904–907.
- Liu S, Ma J, Yue Y-F, et al. Analysis of clinical characteristics and prognostic factors of 223 newly diagnosed Hodgkin’s lymphoma patients. Zhongguo shi yan xue ye xue za zhi. 2015;23(5):1296–1300.
- Zhu Y-J, Sun Y-L, Xia Y, et al. Clinical characteristics and prognostic factors in Chinese patients with Hodgkin’s lymphoma. Med Oncol. 2012;29(2):1127–1133.
- Bröckelmann PJ, Angelopoulou MK, Vassilakopoulos TP. Prognostic factors in Hodgkin lymphoma. Semin Hematol. 2016;53(3):155–164.
- Friedman D. Hodgkin lymphoma In: Lanzkowsky P, Lipton JMFJ, editor. Manual of pediatric hematology and oncology. Cambridge (MA): Academic Press. 2016. p. 429–441.
- Trehan A, Singla S, Marwaha RK, et al. Hodgkin lymphoma in children: experience in a tertiary care centre in India. J Pediatr Hematol Oncol. 2013;35(3):174–179.
- Dinand V, Arya LS. Epidemiology of childhood Hodgkins disease: is it different in developing countries? Indian Pediatr. 2006;43(2):141–147.
- Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood. 2002;99(12):4283–4297.
- Shamoon RP, Ali MD, Shabila NP. Overview and outcome of Hodgkin’s Lymphoma: experience of a single developing country’s oncology centre. PLoS One. 2018;13(4):e0195629.
- Cuccaro A, Bartolomei F, Cupelli E, et al. Prognostic factors in hodgkin lymphoma. Mediterr J Hematol Infect Dis. 2014;6(1):e2014053.
- Khan FS, Hasan RF. Bone marrow in pediatric patients with Hodgkin’s disease. J Ayub Med Coll Abbottabad. 2012;24(2):54–57.
- Munker R, Hasenclever D, Brosteanu O, et al. Bone marrow involvement in Hodgkin’s disease: an analysis of 135 consecutive cases. German Hodgkin’s Lymphoma Study Group. J Clin Oncol. 1995;13(2):403–409.
- Park S, Han B, Cho JW, et al. Effect of nutritional status on survival outcome of diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Nutr Cancer. 2014;66(2):225–233.
- Pribnow AK, Ortiz R, Báez LF, et al. Effects of malnutrition on treatment-related morbidity and survival of children with cancer in Nicaragua. Pediatr Blood Cancer. 2017;64(11):e26590.